Skip to main content
DHC $8.38 +0.12%
DHC logo

DHC · Diversified Healthcare Trust

Track DHC — free
$8.38 +0.01 (+0.12%) At close · Aug 14
Market Cap
$2.03B
Shares
242.13M
All earnings calls

Earnings call · FY2026 Q1

Diversified Healthcare Trust Q1 FY2026 Earnings Call

Diversified Healthcare Trust Q1 FY2026 Earnings Call

Concluded May 5, 2026 Audio replay
May 5, 2026 27:06 35 turns
Period
FY2026 Q1
Runtime
27:06
Sources
4 artifacts

Executive readout · one minute

What matters this quarter

DHC reported Q1 2026 normalized FFO of $33.1 million ($0.14/share) and adjusted EBITDAre of $74 million, both ahead of analyst consensus, with consolidated NOI up 4.7% year-over-year to $75.9 million and same-property SHOP NOI up 13.5% as the AlerisLife operator transition was completed.

SHOP portfolio operating performance 53 Guidance and forward outlook 41 Capital structure and balance sheet 12 Medical Office and Life Science portfolio 12 Operator transitions and expense control 9 Transition execution and seasonality risk 8

Management tone

Confident

Net tone +68 · low hedging

Grounding quotes
  • “DHC delivered a strong first quarter, demonstrating the powerful combination of our active asset management and the deep expertise of our expanded operating partners.”
  • “Our same property shop portfolio delivered a robust 13.5% increase in NOI year-over-year, reaching $44.3 million.”
  • “We reported normalized FFO of $33.1 million, or $0.14 per share, and adjusted EBITDA RE of $74 million, both well ahead of the analyst consensus estimate.”
  • “We are confident that our best-in-class operators and strength and balance sheet will continue to drive superior performance and create significant long-term value for our shareholders.”

Forward guidance

1 guided metrics

Management's latest ranges and targets are included below.

Research coverage

4 live sources

Switch sources without leaving this page or losing your listening position.

Revenue $366.47M -5.3% YoY
Diluted EPS -$0.18
Net income -$43.27M

Research materials

Open the source you need; every reader stays inside this workspace.

Key takeaways

What improved, and what deserves a closer read.

Constructive signals

  • SHOP same-property NOI grew 13.5% year-over-year to $44.3 million, driven by 110 bps occupancy growth and 5.9% average monthly rate growth.
  • SHOP same-property NOI margin expanded 160 bps to 14.9%, supported by an average 4.5% rate increase across 70% of the portfolio and labor/dietary cost savings.
  • Medical Office and Life Science same-property NOI rose 3.7% year-over-year and 4.8% sequentially to $25.4 million, with 169,000 sq ft leased at rents 12% above prior rents.
  • AlerisLife operator transition successfully completed, with DHC guiding to 300 bps occupancy growth and 5%+ rate growth for 2026.
  • Completed $23 million sale of 13 non-core SHOP communities and exercised $14.5 million land lease buyouts expected to generate low-to-mid-teen returns.
  • Initiated a pipeline of six SHOP repositioning projects (~150 units, ~$20 million) at mid-teen expected returns, immediately accretive upon completion.

Risks & pressure points

  • SHOP same-property occupancy was flat sequentially at 82.4%, with management attributing softness to operator transition disruption and seasonality.
  • Management expects Q3 SHOP NOI growth to moderate versus Q2 due to seasonal expenses, before rebounding in Q4.
  • Shop same-property NOI growth of 13.5% (or 22% adjusted for prior-year insurance proceeds) was flattered by an easy prior-year comp.
  • Forward-looking statements are subject to risks and uncertainties, and DHC noted it is not providing GAAP reconciliations for its non-GAAP guidance.

Key moments

Jump directly to management's words in the synchronized transcript.

Forward guidance

From the 8-K filed May 4, 2026.

Metric Guided
SHOP NOI growth
2026
26% – 33%

Quarter detail

How the reported period landed and where the business moved.

Revenue · segments

Senior Housing Operating Portfolio Segment$317.23M -3.4% YoY
Medical Office and Life Science Portfolio Segment$41.90M -15.8% YoY

Capital returned

Buybacks
$88,000
Dividend / share
$0.01
Full-screen source Call document